{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:34:48Z","timestamp":1791254088317,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.jaci.2004.09.038","type":"journal-article","created":{"date-parts":[[2005,1,4]],"date-time":"2005-01-04T07:16:50Z","timestamp":1104823010000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound"],"prefix":"10.1016","volume":"115","author":[{"given":"Isabelle","family":"Vachier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bonnans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Chavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Farce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Godard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.09.038_bib1","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes","volume":"81","author":"Serhan","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.09.038_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-5793(89)81078-6","article-title":"New series of lipoxins isolated from human eosinophils","volume":"255","author":"Steinhilber","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2004.09.038_bib3","first-page":"203","article-title":"Formation of lipoxins and leukotrienes by human alveolar macrophages incubated with 15(S)-HETE: a model for cellular cooperation between macrophages and airway epithelial cells","volume":"5","author":"Chavis","year":"1992","journal-title":"Eicosanoids"},{"key":"10.1016\/j.jaci.2004.09.038_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1084\/jem.183.4.1633","article-title":"5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors","volume":"183","author":"Chavis","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib5","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.09.038_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03401642","article-title":"Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation","volume":"2","author":"Claria","year":"1996","journal-title":"Mol Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1164\/ajrccm\/141.6.1453","article-title":"Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases","volume":"141","author":"Lee","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.09.038_bib8","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1172\/JCI116738","article-title":"Human alveolar macrophages have 15-lipoxygenase and generate15(S)-hydroxy-5, 8,11-cis-13-trans-eicosatetraenoic acid and lipoxins","volume":"92","author":"Levy","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.09.038_bib9","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/rccm.200201-053OC","article-title":"Lipoxins are potential endogenous antiinflammatory mediators in asthma","volume":"165","author":"Bonnans","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib10","series-title":"Lipid mediators in allergic diseases of the respiratory tract","first-page":"65","article-title":"Lipoxins: biosynthesis and evidence for their involvement in respiratory disease","author":"Serhan","year":"1994"},{"key":"10.1016\/j.jaci.2004.09.038_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2004.09.038_bib12","first-page":"380","article-title":"Lipoxins: novel anti-inflammatory therapeutics?","volume":"1","author":"Godson","year":"2000","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2004.09.038_bib13","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","article-title":"Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo","volume":"13","author":"Mitchell","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaci.2004.09.038_bib14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1067\/mai.2001.113868","article-title":"Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma","volume":"107","author":"Vachier","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.09.038_bib15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4)","volume":"8","author":"Levy","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci"},{"key":"10.1016\/j.jaci.2004.09.038_bib17","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/archinte.1986.00360240095016","article-title":"Natural history of asthma in patients requiring long-term systemic corticosteroids","volume":"146","author":"Dykewics","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/ajrccm.156.3.9610046","article-title":"Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids","volume":"156","author":"Wenzel","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1183\/09031936.99.13101599","article-title":"Prednisone-dependent asthma: inflammatory indices in induced sputum","volume":"13","author":"Pizzichini","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2004.09.038_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1183\/09031936.99.13612539","article-title":"Mucosal inflammation in severe glucocorticoid-dependent asthma","volume":"13","author":"Vrugt","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2004.09.038_bib21","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","article-title":"Neutrophilic inflammation in severe persistent asthma","volume":"160","author":"Jatakanon","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1164\/ajrccm.154.2.8756824","article-title":"Leukocyte recruitment after local endobronchial allergen challenge in asthma: relationship to procedure and to airway interleukin-8 release","volume":"15","author":"Teran","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0009-9120(90)90272-V","article-title":"Biosynthesis and biological activity of leukotriene B4","volume":"23","author":"Borgeat","year":"1990","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jaci.2004.09.038_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1034\/j.1399-3003.2000.15b09.x","article-title":"Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4","volume":"15","author":"Crooks","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2004.09.038_bib26","doi-asserted-by":"crossref","first-page":"C1249","DOI":"10.1152\/ajpcell.2000.279.4.C1249","article-title":"15(S)-HETE modulates LTB(4) production and neutrophil chemotaxis in chronic bronchitis","volume":"279","author":"Profita","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jaci.2004.09.038_bib27","first-page":"225","article-title":"Official statement of the American Thoracic Society adopted by the ATS Board of Directors, November 1986","volume":"136","author":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.09.038_bib28","unstructured":"WHO\/NHLBI Workshop report. Global strategy for asthma management and prevention. Publication #02-3659. Bethesda (MD): National Institutes of Health\/National Heart, Lung, and Blood Institute; 2002."},{"key":"10.1016\/j.jaci.2004.09.038_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/ajrccm.162.1.9911032","article-title":"Glucocorticoid receptor alpha and beta in glucocorticoid-dependent asthma","volume":"162","author":"Gagliardo","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1183\/09031936.01.0027401","article-title":"Global initiative for chronic obstructive lung diseases (GOLD): time to act","volume":"18","author":"Pauwels","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2004.09.038_bib31","first-page":"9S","article-title":"Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma","volume":"26","author":"Kips","year":"1998","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaci.2004.09.038_bib32","first-page":"3S","article-title":"Sputum induction","volume":"37","author":"Paggiaro","year":"2002","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaci.2004.09.038_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/thx.47.1.25","article-title":"Use of induced sputum cell counts to investigate airway inflammation in asthma","volume":"47","author":"Pin","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2004.09.038_bib34","first-page":"9S","article-title":"Safety of sputum induction","volume":"37","author":"Pizzichini","year":"2002","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaci.2004.09.038_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/thx.51.3.267","article-title":"Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils","volume":"51","author":"Stanescu","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2004.09.038_bib36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma","volume":"22","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2004.09.038_bib37","first-page":"24s","article-title":"Analysis of fluid-phase mediators","volume":"37","author":"Kelly","year":"2002","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaci.2004.09.038_bib38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.LAB.0000028823.53486.4A","article-title":"Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins","volume":"82","author":"Romano","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaci.2004.09.038_bib39","first-page":"L413","article-title":"Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases","volume":"264","author":"Richman-Eisenstat","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaci.2004.09.038_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0090-6980(97)00001-4","article-title":"Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?","volume":"53","author":"Serhan","year":"1997","journal-title":"Prostaglandins"},{"key":"10.1016\/j.jaci.2004.09.038_bib41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/ajrccm.161.2.9811063","article-title":"Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease","volume":"161","author":"Taha","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.09.038_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/20024091064273","article-title":"Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung","volume":"32","author":"Hukkanen","year":"2002","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.jaci.2004.09.038_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/abio.1998.2897","article-title":"Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS","volume":"265","author":"Bylund","year":"1998","journal-title":"Anal Biochem"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904026223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904026223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:54:58Z","timestamp":1758776098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904026223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0091674904026223"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.09.038","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}